Rib Fractures, Spirometry
Conditions
Brief summary
Respiratory physiotherapy is routinely performed after thoracic surgery operations to increase lung expansion and prevent pulmonary complications such as atelectasis and pneumonia. It is a controversial issue whether respiratory physiotherapy reduces pulmonary complications in rib fractures. In our study, patients with rib fractures will be divided into two groups. In the control group, standard treatment consisting of routine analgesic treatments will be applied. In the other group, respiratory physiotherapy will be applied with triflu for 8 hours a day. At the end of the study, pulmonary complications in both groups will be compared.
Detailed description
Patients between the ages of 18 and 100 who will apply to our hospital due to rib fractures between April 2024 and April 2025 will be evaluated. Patients who meet the inclusion criteria will be included in the study. Patients will be divided into two groups using randomization blocks. Patients in the control group will receive conservative treatment consisting of paracetamol and dexketoprofen. In the other group of patients, in addition to conservative treatment, triflow breathing exercise will be applied for 8 hours a day. Respiratory function test pain scores and pulmonary complications of patients in the two groups will be compared statistically.
Interventions
In this group of patients, in addition to routine analgesic treatment, triflow use and deep breathing training would be given by the physiotherapist. Patients in this group will do breathing exercises 8 hours a day, 10 times an hour.
Patients in the control group will receive conservative treatment consisting of paracetamol and dexketoprofen.
Sponsors
Study design
Eligibility
Inclusion criteria
* Isolated thoracic injury within 24 hours * Age between 18-100
Exclusion criteria
* Pneumothorax and hemothorax requiring intervention at admission * Injury severity index \>16 * COPD, Atshma * Extrathoracic trauma
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| FEV1, FVC, FEV1/FVC results on day 7 | 7 days | FEV1, FVC, FEV1/FVC |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of Participants with Pneumonia | 7 days | Clinical and radiological diagnosis of pneumonia |
| FEV1, FVC, FEV1/FVC results on day 2 | 2 days | FEV1, FVC, FEV1/FVC |
Countries
Turkey (Türkiye)